Results 11 to 20 of about 419,158 (294)
Human Vaccines & Immunotherapeutics, 2022 Acceptance of COVID-19 vaccine among health-care workers (HCWs) is crucial for controlling the pandemic and ensuring HCW and patient safety. Information on the acceptance of different COVID-19 vaccines is lacking.
Basema Saddik +9 more
doaj +1 more source
Industrial Psychiatry Journal, 2021 “Necessity is the mother of invention:” An adage was brought to life with the emergence of the mRNA vaccine against the backdrop of the foreboding and mercurial COVID-19 pandemic.
Tahoora Ali +4 more
doaj +1 more source
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). [PDF]
, 2020 OBJECTIVES: To investigate the efficacy and safety of ixekizumab for up to 52 weeks in two phase 3 studies of patients with active radiographic axial spondyloarthritis (r-axSpA) who were biological disease-modifying antirheumatic drug (bDMARD)-naive ...
Baraliakos, X. +19 more
core +3 more sources
Biomedical and Biotechnology Research Journal, 2022 Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines represent the only way in combating the COVID-19 pandemic. Studying the differences in immune response to different types of vaccines is considered an important tool for ...
Rawaq Taleb Hassan, Suhad H Mohammed
doaj +1 more source
A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine
Journal of Community Hospital Internal Medicine Perspectives, 2021 Since the first-reported case of Severe Acute Respiratory Distress Syndrome-Coronavirus 2 in December 2019, COVID-19 has caused a global pandemic associated with significant morbidity and mortality.
Shiavax J. Rao +5 more
doaj +1 more source
Scotland Registry for Ankylosing Spondylitis (SIRAS) – Protocol [PDF]
, 2016 Funding SIRAS was funded by unrestricted grants from Pfizer and AbbVie. The project was reviewed by both companies, during the award process, for Scientific merit, to ensure that the design did not compromise patient safety, and to assess the global ...
Dean, Linda E +10 more
core +1 more source
Prediction of progression-free survival in patients with advanced, well-differentiated, neuroendocrine tumors being treated with a somatostatin analog: the GETNE-TRASGU study [PDF]
, 2019 Artículo escrito por un elevado número de autores, sólo se referencian el que aparece en primer lugar, y los autores pertenecientes a la UAMSomatostatin analogs (SSAs) are recommended for the first-line treatment of most patients with well ...
Carmona Bayonas, Alberto +1 more
core +1 more source
Direct control of CAR T cells through small molecule-regulated antibodies
Nature Communications, 2021 Many next-generation antibody therapeutics have enhanced potency but the risk of adverse events. Here the authors develop a conditionally activated, single-module CAR.
Spencer Park +14 more
doaj +1 more source
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. [PDF]
, 2013 BACKGROUND: Riociguat, a member of a new class of compounds (soluble guanylate cyclase stimulators), has been shown in previous clinical studies to be beneficial in the treatment of chronic thromboembolic pulmonary hypertension. METHODS: In this phase 3,
CHEST-1 Study Group, +13 more
core +1 more source
Psychosocial rehabilitation:a model by Rajah Rehabilitation Centre
Kerala Journal of Psychiatry, 2019 ‘Thanal’- Rajah Rehabilitation Centre (RRC) is a nonprofit voluntary organization established in 2001 dedicated to the people suffering from psychiatric illness. RRC adopts an interdisciplinary team approach for the upliftment of the disabled.
Nechiyilthody Pfizer, M A Kavitha
doaj +3 more sources